{
  "id": "5abc9157fcf456587200001e",
  "type": "summary",
  "question": "What is \"enhancer hijacking\"?",
  "ideal_answer": "Enhancer hijacking is the molecular process through which a structural variant removes or moves a TAD boundary to expose TSSs to regulatory enhancers from which they would normally be insulated.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29059320",
    "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
    "http://www.ncbi.nlm.nih.gov/pubmed/26229090",
    "http://www.ncbi.nlm.nih.gov/pubmed/28726821"
  ],
  "snippets": [
    {
      "text": "Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Here we present a framework for inferring cancer-related gene overexpression resulting from CRE reorganization (e.g., enhancer hijacking) by integrating SCNAs, gene expression data and information on topologically associating domains (TADs).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We additionally pursued cancer-type-specific analyses and uncovered IGF2 as a target for enhancer hijacking in colorectal cancer. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "New molecular subtypes were differentially enriched for specific driver events, including hotspot in-frame insertions that target KBTBD4 and 'enhancer hijacking' events that activate PRDM6.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28726821",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Importantly, such variants could affect enhancer regulation by changing transcription factor bindings or enhancer hijacking, and in turn, make an essential contribution to disease progression.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29059320",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We demonstrate a novel approach for simultaneous detection of genomic rearrangements and enhancer activity in tumor biopsies. We identify novel mechanisms of enhancer-driven regulation of the oncogenes MYC and BCL6, and show that the BCL6 locus can serve as an enhancer donor in an \"enhancer hijacking\" translocation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26229090",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}